01/05/2026
🐾PetCure Oncology specializes in treating pet lung tumors, particularly primary tumors, using advanced Stereotactic Radiosurgery (SRS/SRT) as a non-invasive alternative to surgery, offering highly targeted radiation to shrink tumors, improve quality of life, and potentially extend survival for dogs with hard-to-treat masses or when surgery isn't an option. 🐾
They run clinical trials for these conditions, providing subsidized treatment, and aim to make this technology accessible through their network of centers, focusing on better outcomes with fewer side effects than traditional radiation or surgery.
What PetCure Oncology Offers for Lung Tumors:
Stereotactic Radiosurgery (SRS/SRT): A precise, non-surgical radiation treatment that delivers high doses directly to the tumor, sparing surrounding healthy tissue.
Clinical Trials: They offer trials for primary lung tumors in dogs, providing subsidized treatment and follow-up scans to gather data on efficacy.
Benefits of SRS: Fewer treatments, shorter sessions, reduced side effects, and improved quality of life compared to conventional methods.
Accessibility: Growing network of centers in the U.S. to provide advanced care.
Why SRS for Lung Tumors?
Challenging Location: Lung tumors are near vital organs, making traditional radiation difficult and surgery invasive.
Effective Alternative: SRS is showing success in shrinking tumors, controlling cancer, and improving survival in dogs that can't undergo surgery.
When to Consider PetCure Oncology:
If your dog has a small, primary (not spread) lung tumor.
If your dog is not a good candidate for surgery.
If you're seeking a less invasive treatment with fewer side effects than conventional radiation.
Key Takeaway: PetCure Oncology is at the forefront of using advanced SRS/SRT for pet lung tumors, offering a promising, less-invasive option for better pet outcomes.
